Heilongjiang Zhenbao Island Pharmaceutical Co., Ltd. issued a prompt announcement regarding changes in the equity of its controlling shareholder. From August 2 to September 18, the two phases of exchangeable bonds issued by the controlling shareholder Chuangda Group converted 9,223,963 shares, accounting for 0.98% of the total share capital; as of September 18, a total of 16,550,986 shares had been converted, accounting for 1.76%. After this equity change, Chuangda Group's shareholding ratio decreased from 60.85% to 59.87%, crossing the 60% threshold. This change is due to the bondholders' conversion of shares, resulting in a passive reduction in holdings, which does not trigger a tender offer and will not change the company's controlling shareholder and actual controller. The company will continue to monitor the share conversion matter and disclose information in accordance with regulations, reminding investors to pay attention to risks